RJW & partners
Consultancy providing pricing, reimbursement and market access advisory services for biotechnology and pharmaceutical organisations. Offers payer research, HEOR/HTA support, pricing and launch-sequence modelling, value communication and payer-facing negotiation training, with projects across developed and emerging markets.
Industries
Nr. of Employees
small (1-50)
RJW & partners
Products
Packaged HTA toolkit
A set of HTA planning tools and templates including landscape overviews, HTA timelines, decision-problem templates, core value dossier templates and submission documentation designed to accelerate HTA strategy development.
Packaged HTA toolkit
A set of HTA planning tools and templates including landscape overviews, HTA timelines, decision-problem templates, core value dossier templates and submission documentation designed to accelerate HTA strategy development.
Services
Advisory services covering pricing strategy, launch sequencing, reference pricing analysis and market access planning across product lifecycle stages.
Services include evidence gap analysis, early economic modelling, budget impact models, HTA monitoring and submission support.
Landscape analysis of payer environments using secondary research, interviews and advisory boards to inform pricing and corporate strategy.
Design and delivery of negotiation workshops and mock negotiations with payer panels to prepare affiliate teams for payer engagements.
Organisation and facilitation of payer advisory boards and primary research to test value messages, contracting designs and pricing scenarios.
Advisory services covering pricing strategy, launch sequencing, reference pricing analysis and market access planning across product lifecycle stages.
Services include evidence gap analysis, early economic modelling, budget impact models, HTA monitoring and submission support.
Landscape analysis of payer environments using secondary research, interviews and advisory boards to inform pricing and corporate strategy.
Design and delivery of negotiation workshops and mock negotiations with payer panels to prepare affiliate teams for payer engagements.
Organisation and facilitation of payer advisory boards and primary research to test value messages, contracting designs and pricing scenarios.
Expertise Areas
- Pricing and reimbursement strategy
- Health economics and outcomes research (HEOR)
- Health technology assessment (HTA) support
- Payer and KOL primary research
Key Technologies
- Health economic modelling
- Budget impact analysis
- Price and launch-sequence modelling
- Sales forecasting models
News & Updates
Participation at World EPA Congress, booth presence reported for 12-13 March 2024.
Insight article comparing early access programmes across Europe and other regions.
Article discussing payer perspectives on the affordability of cell and gene therapies.
Article on expanded access programs and the market opportunity in Brazil.
Participation at World EPA Congress, booth presence reported for 12-13 March 2024.
Insight article comparing early access programmes across Europe and other regions.
Article discussing payer perspectives on the affordability of cell and gene therapies.
Article on expanded access programs and the market opportunity in Brazil.